Managed Healthcare Executive May 3, 2024
Peter Wehrwein, Managing Editor

Health plans that use Optum Rx as their pharmacy benefit manager (PBM) will be allowed to tier their coverage of GLP-1s and still receive rebates under an agreement the PBM has reached with the manufacturers, says the PBM president.

Optum Rx has reached an agreement with the manufacturers of the approved glucagon-like peptide 1 (GLP-1s) drugs that will allow health plans to tier access to the drugs and still receive a rebate.

In an interview with Managed Healthcare Executive (MHE) at the Asembia specialty pharmacy meeting in Las Vegas this week, Jon Mahrt, president and chief operating officer of Optum Rx, said that rebates have been contingent upon health plans covering according to criteria included in the FDA-approved label.

Mahrt...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Insurance, Payer, Pharma, Pharma / Biotech
Why Walgreens Specialty Pharmacy May Be Its Most Desirable Asset
AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic
2025 Drugs to Watch: Market Access, Innovation, and the Future of Reimbursement
Confronting Pharmacy Deserts: Rethinking Central Fill Automation for Improved Access
How AI Is Transforming The Pharmaceutical Industry

Share This Article